Atlas Trials

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Clinical trial NCT05673603 · COMPLETED

Trial details

NCT number
NCT05673603
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2021-07-20
Primary completion
2023-02-14
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.